<Record>
<Term>gp-120 Antigen</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Vaccine Antigen</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Agent/Antigen/Vaccine Antigen/gp-120 Antigen</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Biological Agent</BroaderTerm>
<BroaderTerm>Antigen</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Vaccine Antigen</BroaderTerm>
<BroaderTerm>gp-120 Antigen</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>gp-120</Synonym>
<Synonym>gp-120 Antigen</Synonym>
<Description>A recombinant HIV gp120 envelope protein with potential use in HIV vaccine therapy. Gp-120 antigen is used to elicit a gp120-specific T-cell response. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
